Pharsight

1. Cetylev patents expiration

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8747894	ARBOR PHARMS LLC	Effervescent compositions containing N-acetylcysteine	May, 2032 (8 years from now)
US9427421	ARBOR PHARMS LLC	Effervescent compositions containing N-acetylcysteine	May, 2032 (8 years from now)
US9561204	ARBOR PHARMS LLC	Effervescent compositions containing N-acetylcysteine	May, 2032 (8 years from now)

Market Authorisation Date: 29 January, 2016

Treatment: Method of treating acetaminophen overdose with acetylcysteine solutions

Dosage: TABLET, EFFERVESCENT;ORAL

Strength	Dosage	Availability
2.5GM	TABLET, EFFERVESCENT;ORAL	Discontinued
500MG	TABLET, EFFERVESCENT;ORAL	Discontinued

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6103248	ARBOR PHARMS LLC	Topical preparation and therapy for head lice	May, 2018 (5 years ago)
US8791153	ARBOR PHARMS LLC	Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice	Oct, 2027 (3 years from now)
US8927595	ARBOR PHARMS LLC	Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice	Oct, 2027 (3 years from now)

Drug Exclusivity	Drug Exclusivity Expiration
New Product(NP)	Feb 07, 2015

Market Authorisation Date: 07 February, 2012

Treatment: For head lice infestations

Dosage: LOTION;TOPICAL